Success of Weekly Adalimumab in Refractory Ocular Inflammatory Disease - ScienceDirect

View PDF

Ophthalmology

Volume 127, Issue 10, October 2020, Pages 1431-1433

Ophthalmology

Presented at: the 24th Annual American Uveitis Society Meeting, Salt Lake City, Utah, January 18, 2020.

https://doi.org/10.1016/j.ophtha.2020.04.009 Get rights and content

Cited by (0)

: Financial Disclosure(s): The author(s) have made the following disclosure(s): D.A.G.: Consultant and participated in review activities – AbbVie Inc.; Consultant – Adverum.

: J.L.: Grant – Illinois Society for the Prevention of Blindness; Support for travel – American Uveitis Society and National Eye Institute.

: Supported by the Illinois Society for the Prevention of Blindness, Chicago, Illinois (grant no. SP0056834).

: HUMAN SUBJECTS: Human subjects were included in this study. The human ethics committee at Northwestern University approved the study. All research adhered to the tenets of the Declaration of Helsinki. This is a retrospective study of de-identified patients.

: No animal subjects were used in this study.

: Author Contributions:

: Conception and design: Lee, Goldstein

: Data collection: Lee, Goldstein

: Analysis and interpretation: Lee, Koreishi, Zumpf, Minkus, Goldstein

: Obtained funding: Lee, Goldstein

: Overall responsibility: Lee, Koreishi, Zumpf, Minkus, Goldstein

© 2020 by the American Academy of Ophthalmology